Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

NCT02120066 — Not applicable, Completed, 22 participants, Kyorin University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT02120066
StatusCompleted
PhaseNot applicable
Study typeInterventional; na, single group, masking: none, treatment
Enrollment22 (Actual)
SponsorKyorin University (Other)
ConditionsSubmacular Hemorrhage, Ruptured Retinal Arterial Macro Aneurysms
InterventionsVitrectomy for submacular hemorrhage, subretinal injection of tissue-plasminogen activator (Procedure, drug)
Datesstart 2011-01-01, primary completion 2013-06-01, completion 2014-04-01, first posted 2014-04-22, last updated 2014-04-22
Locations1 site in Japan

Related Papers Related Patents Related Grants Related Experts
All trials for Submacular Hemorrhage All trials for Ruptured Retinal Arterial Macro Aneurysms All trials of Vitrectomy for submacular hemorrhage All trials of subretinal injection of tissue-plasminogen activator

-Summary

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
VitrectomyOtherProcedure: Vitrectomy for submacular hemorrhage; Drug: subretinal injection of tissue-plasminogen activator
  • Vitrectomy for submacular hemorrhage (Procedure)
  • subretinal injection of tissue-plasminogen activator (Drug)

+Outcome measures

Primary outcomes

  • Displacement of sub macular hemorrhage [one year]: Anatomical recovery detected funduscopy and optical coherence tomography

Secondary outcomes

  • Visual acuity [one year]: Visual recovery after surgery

+Eligibility

Sex: All, ages: 40 Years to 95 Years

Inclusion Criteria:

* The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms

Exclusion Criteria:

* The eyes with preretinal or intraretinal hemorrhage at the fovea
* The patients with follow-up less than 3 months

+Locations (1)

FacilityCityCountryStatus
Kyorin Eye CenterMitaka, TokyoJapan